NASONEX (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the NASONEX drug offered from Merck Sharp & Dohme Corp.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
NON-PROPRIETARY NAME: | Mometasone furoate monohydrate |
SUBSTANCE NAME: | MOMETASONE FUROATE MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-10-01 |
END MARKETING DATE: | 0000-00-00 |
NASONEX HUMAN PRESCRIPTION DRUG Details:
Item Description | NASONEX from Merck Sharp & Dohme Corp. |
LABELER NAME: | Merck Sharp & Dohme Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(ug/1) |
START MARKETING DATE: | 1997-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0085-1288_64c52e50-dc68-43cd-b73d-bb6542997f2a |
PRODUCT NDC: | 0085-1288 |
APPLICATION NUMBER: | NDA020762 |
Other MOMETASONE FUROATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers: